Bio-Techne (TECH) Invested Capital (2009 - 2026)

Bio-Techne's Invested Capital history runs 18 years deep, the most recent figure standing at $2.1 billion for Q1 2026.

• In Q1 2026, Invested Capital rose 3.33% year-over-year to $2.1 billion; the TTM figure through Mar 2026 stood at $2.1 billion (up 3.33% YoY), while the FY2025 annual figure was $1.9 billion, down 7.25% from the prior year.
• Invested Capital was $2.1 billion for Q1 2026 at Bio-Techne, up from $2.0 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $2.1 billion in Q3 2024 to a low of $1.8 billion in Q3 2022.
• Historically, Invested Capital has averaged $2.0 billion across 5 years, with a median of $2.0 billion in 2022.
• The sharpest annual moves came in 2022 and 2023: Invested Capital retreated 9.69% in 2022, then advanced 13.7% in 2023.
• A 5-year view of Invested Capital shows it stood at $1.8 billion in 2022, then grew by 7.47% to $2.0 billion in 2023, then gained by 5.85% to $2.1 billion in 2024, then declined by 3.25% to $2.0 billion in 2025, then gained by 3.7% to $2.1 billion in 2026.
• The last three Invested Capital figures came in at $2.1 billion (Q1 2026), $2.0 billion (Q4 2025), and $2.0 billion (Q3 2025), per Business Quant data.